CAALYX

Older people's autonomy and self-confidence can be greatly increased by wearing a light device that measure vital signs, detect falls, and automatically raise an alert to their care centre in case of an emergency.

Europe is about to face a significant social change, brought about by an unprecedented demographic change: the ratio of elderly people to the entire population is steadily growing, while the ratio of younger age groups, especially the working population is shrinking.

CAALYX's main objective is to develop a wearable light device able to measure specific vital signs of the elderly, to detect falls and to communicate automatically in real time with his/her care provider in case of an emergency, wherever the elderly person happens to be, at home or outside.

Specifically, CAALYX' objectives are:

  • To identify which vital signs and patterns are more relevant to determine probable critical states of an elder's health.
  • To develop an electronic device able to measure vital signs and to detect falls of the aged person at the domestic environment and outside. This gadget will have a geolocation system so that the monitoring system may be able to know the elder's position in case of emergency (especially outdoors).
  • To allow for the secure monitoring of individuals organised into groups managed by a caretaker who will decide whether to promote raised events to the emergency service (112).
  • To create social tele-assistance services that can be easily operated by users.

For further information, please visit:
http://www.caalyx.eu

Project co-ordinator:
Telefónica Investigación y Desarrollo SA Unipersonal

Partners:

  • Inesc Porto-Instituto de Engenharia de Sistemas e Computadores do Porto (Portugal)
  • Cooperativa Sociale Cooss Marche Onlus Societa Cooperativa per Azioni (IT)
  • Synkronix Incorporation Limited (UK)
  • University of Plymouth (UK)
  • University of Limerick (Ireland)
  • Fundació Hospital Comarcal Sant Antoni Abat (SP)
  • Corscience Gmbh & Co KG (Germany)

Timetable: 01/01/2007 - 31/12/2008

Total cost: € 2.962.087,23

EC funding: € 1.850.000,00

Instrument: STREP

Project Identifier: IST-2005-045215

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...